Therapeutics: Src homology protein tyrosine phosphatase 2 (SHP-2; SHPTP2; PTPN11); receptor tyrosine kinase (RTK)

Cancer

INDICATION: Cancer; leukemia

In vitro, cell culture and mouse studies identified a SHP-2 inhibitor that

Read the full 141 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE